NSEAnalysts/Institutional Investor Meet/Con. Call Updates5d ago · 25 Aug 2026, 04:28 pm
Analysts/Institutional Investor Meet/Con. Call Updates
Syngene International Limited · SYNGENE
✦ AI SummaryMgmt Change
Syngene International Limited has informed the Exchange about the schedule of a meeting with analysts/institutional investors, to be held on August 31, 2026, and September 1, 2026, in Hong Kong. The company will not disclose any unpublished price sensitive information during the meeting.
Analysis Scores
Earnings Impact5/10
Growth Catalyst5/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk5/10
Liquidity Impact5/10
Market Sentiment5/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
Syngene International Limited has informed the Exchange about Schedule of meet
Attachments (1)
📄pdf
Download →
SYNGENE2_25082026162720_Investorcallintimation31-01092026.pdf
View document text
Ref: Syn/CS/SE/Reg 30/2026-27/Aug/05 Syngene International Limited
Biocon SEZ, Biocon Park, Plot No. 2 &
3, Bommasandra Industrial Area, IV
Phase, Jigani Link Road, Bengaluru
560 099, Karnataka, India
T +91 80 6891 9191
CIN: L85110KA1993PLC014937
August 25, 2026 www.syngeneintl.com
To, To,
The Manager, The Manager,
BSE Limited National Stock Exchange of India Limited
Corporate Relationship Department Corporate Communication Department
Dalal Street, Mumbai – 400 001 Bandra (EAST), Mumbai – 400 051
Scrip Code: 539268 Scrip Symbol: SYNGENE
Dear Sir/Ma’am,
Subject: Intimation of Schedule of Meeting with Analyst/Institutional Investor
Pursuant to Regulation 30(6) of the SEBI (Listing Obligations and Disclosure Requirements)
Regulations, 2015, please find below the details of the meeting to be held with the
Analyst/Institutional Investor.
Sl. Date Name of the Type of Nature of Venue
No. Analyst/Investor meeting meeting
1. August 31, 2026- Goldman Sachs Asia In Person Group / One- Hong Kong
September 1, Leaders Conference on-one
2026 2026 Meeting
It is hereby notified that the Company shall not be disclosing any Unpublished Price Sensitive
Information (UPSI) during the upcoming analyst/investor meeting.
The above-mentioned information will also be made available on the website of the Company
www.syngeneintl.com.
Request to kindly take this intimation on record.
Thanking You,
Yours faithfully,
For SYNGENE INTERNATIONAL LIMITED
Chethan Yogesh
Company Secretary & Compliance Officer